Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.14% is 68% below its 1-year average of -16.76%, near the low end of its 1-year range (-28.14%–-9.93%).
As of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.14%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+21.07%
vs the sector median at left
LB Pharmaceuticals Inc Common Stock
Market Cap
$982.46M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
Return on Invested Capital (ROIC)
52.81%
TTM Avg
-75.45%
3Y Avg
-63.24%
5Y Avg
-50.31%
Market Cap
$978.09M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$973.93M
Return on Invested Capital (ROIC)
1.35%
TTM Avg
-1.75%
3Y Avg
1.09%
5Y Avg
1.96%
Market Cap
$992.14M
Return on Invested Capital (ROIC)
-32.24%
TTM Avg
-91.06%
3Y Avg
-69.60%
5Y Avg
-62.21%
Market Cap
$996.65M
Return on Invested Capital (ROIC)
-27.51%
TTM Avg
-21.69%
3Y Avg
-25.73%
5Y Avg
-26.71%
Market Cap
$998.69M
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-46.08%
3Y Avg
-28.67%
5Y Avg
-26.80%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
Market Cap
$953.81M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LB Pharmaceuticals Inc Common Stock (LBRX) | $982.46M | -28.14% | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 52.81% | -75.45% | -63.24% | -50.31% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 1.35% | -1.75% | 1.09% | 1.96% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | -32.24% | -91.06% | -69.60% | -62.21% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -27.51% | -21.69% | -25.73% | -26.71% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -68.64% | -46.08% | -28.67% | -26.80% |
| Immatics N.V. (IMTX)vs › | $1.01B | -53.36% | -19.72% | -15.42% | -34.93% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -16.54% | -24.45% | -23.43% | -23.43% |
| Savara Inc. (SVRA)vs › | $952.91M | -82.30% | -52.55% | -42.51% | -41.57% |
ROIC
-28.1%
ROE
-25.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.14% |
| 2026-03-31 | -12.23% |
| 2025-12-31 | -9.93% |
